{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:47:41Z","timestamp":1785750461564,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Korea Institute of Drug Safety and Risk Management"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim. Care Respir. Med."],"DOI":"10.1038\/s41533-026-00523-4","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:23:56Z","timestamp":1778858636000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative risk of pneumonia and acute exacerbation between P-CAB and PPI use in patients with COPD and GERD"],"prefix":"10.1038","volume":"36","author":[{"given":"SooBeen","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung Ju","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk Soon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hankil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9429-8711","authenticated-orcid":false,"given":"Ha-Lim","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"523_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-21414-2","volume":"25","author":"Y Zhu","year":"2025","unstructured":"Zhu, Y. et al. Global, regional, and national burden of young COPD, 1990\u20132021, with forecasts to 2050: a systematic analysis for the global burden of disease study 2021. BMC Public. Health 25, 276 (2025).","journal-title":"BMC Public. Health"},{"key":"523_CR2","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1465-9921-15-62","volume":"15","author":"CH Martinez","year":"2014","unstructured":"Martinez, C. H. et al. Impact of self-reported Gastroesophageal reflux disease in subjects from COPDGene cohort. Respir. Res. 15, 62 (2014).","journal-title":"Respir. Res."},{"key":"523_CR3","doi-asserted-by":"publisher","first-page":"E27091","DOI":"10.1097\/MD.0000000000027091","volume":"100","author":"HH Kang","year":"2021","unstructured":"Kang, H. H. et al. Reflux esophagitis in patients with chronic obstructive pulmonary disease. Medicine 100, E27091 (2021).","journal-title":"Medicine"},{"key":"523_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/resp.12420","volume":"20","author":"TS Ingebrigtsen","year":"2015","unstructured":"Ingebrigtsen, T. S. et al. Gastro-esophageal reflux disease and exacerbations in chronic obstructive pulmonary disease. Respirology 20, 101\u2013107 (2015).","journal-title":"Respirology"},{"key":"523_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12931-023-02345-1","volume":"24","author":"J Kang","year":"2023","unstructured":"Kang, J., Lee, R. & Lee, S. W. Effects of gastroesophageal reflux disease treatment with proton pump inhibitors on the risk of acute exacerbation and pneumonia in patients with COPD. Respir. Res. 24, 75 (2023).","journal-title":"Respir. Res."},{"key":"523_CR6","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/resp.12758","volume":"21","author":"L Baumeler","year":"2016","unstructured":"Baumeler, L. et al. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD. Respirology 21, 883\u2013890 (2016).","journal-title":"Respirology"},{"key":"523_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s00535-023-02007-5","volume":"58","author":"J Maret-Ouda","year":"2023","unstructured":"Maret-Ouda, J., Panula, J., Santoni, G., Xie, S. & Lagergren, J. Proton pump inhibitor use and risk of pneumonia: a self-controlled case series study. J. Gastroenterol. 58, 734\u2013740 (2023).","journal-title":"J. Gastroenterol."},{"key":"523_CR8","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD: (2025) Report. https:\/\/goldcopd.org\/2025-gold-report\/."},{"key":"523_CR9","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5056\/jnm18029","volume":"24","author":"T Oshima","year":"2018","unstructured":"Oshima, T. & Miwa, H. Potent potassium-competitive acid blockers: a new era for the treatment of acid-related diseases. J. Neurogastroenterol. Motil. 24, 334\u2013344 (2018).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"523_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11894-024-00939-3","volume":"26","author":"C Scarpignato","year":"2024","unstructured":"Scarpignato, C. & Hunt, R. H. Potassium-competitive acid blockers: current clinical use and future developments. Curr. Gastroenterol. Rep. 26, 273\u2013293 (2024).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"523_CR11","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1111\/jgh.16017","volume":"37","author":"DM Simadibrata","year":"2022","unstructured":"Simadibrata, D. M., Syam, A. F. & Lee, Y. Y. A comparison of efficacy and safety of potassium-competitive acid blocker and proton pump inhibitor in gastric acid-related diseases: a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 37, 2217\u20132228 (2022).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"523_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.14309\/ajg.0000000000002714","volume":"119","author":"Q Zhuang","year":"2024","unstructured":"Zhuang, Q. et al. Comparative efficacy of P-CAB vs proton pump inhibitors for grade C\/D esophagitis: a systematic review and network meta-analysis. Am. J. Gastroenterol. 119, 803\u2013813 (2024).","journal-title":"Am. J. Gastroenterol."},{"key":"523_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.5056\/jnm21077","volume":"27","author":"HK Jung","year":"2021","unstructured":"Jung, H. K. et al. 2020 Seoul consensus on the diagnosis and management of gastroesophageal reflux disease. J. Neurogastroenterol. Motil. 27, 453\u2013481 (2021).","journal-title":"J. Neurogastroenterol. Motil."},{"key":"523_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","volume":"167","author":"A Patel","year":"2024","unstructured":"Patel, A., Laine, L., Moayyedi, P. & Wu, J. AGA clinical practice update on integrating potassium-competitive acid blockers into clinical practice: expert review. Gastroenterology 167, 1228\u20131238 (2024).","journal-title":"Gastroenterology"},{"key":"523_CR15","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758\u2013764 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"523_CR16","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n, M. A., Wang, W. & Leaf, D. E. Target trial emulation: a framework for causal inference from observational data. JAMA 328, 2446\u20132447 (2022).","journal-title":"JAMA"},{"key":"523_CR17","unstructured":"Enhancing the QUAlity and Transparency Of health Research. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. http:\/\/www.equator-network.org\/reporting-guidelines\/strobe\/."},{"key":"523_CR18","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/apt.15185","volume":"49","author":"KJ Lee","year":"2019","unstructured":"Lee, K. J. et al. Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis. Aliment. Pharmacol. Ther. 49, 864\u2013872 (2019).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"523_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jama.2023.4221","volume":"329","author":"SV Wang","year":"2023","unstructured":"Wang, S. V. et al. Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials. JAMA 329, 1376\u20131385 (2023).","journal-title":"JAMA"},{"key":"523_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.4097\/kja.23278","volume":"76","author":"E Ahn","year":"2023","unstructured":"Ahn, E. & Kang, H. Intention-to-treat versus as-treated versus per-protocol approaches to analysis. Korean J. Anesthesiol. 76, 531\u2013539 (2023).","journal-title":"Korean J. Anesthesiol."},{"key":"523_CR21","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum, P. R. & Rubin, D. B. Reducing bias in observational studies using subclassification on the propensity score reducing bias in observational studies using subclassification on the propensity score. J. Am. Stat. Assoc. 79, 516\u2013524 (1984).","journal-title":"J. Am. Stat. Assoc."},{"key":"523_CR22","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin, P. C. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat. Med. 28, 3083\u20133107 (2009).","journal-title":"Stat. Med."},{"key":"523_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1183\/09059180.00002509","volume":"18","author":"RS Morehead","year":"2009","unstructured":"Morehead, R. S. Gastro-oesophageal reflux disease and non-asthma lung disease. Eur. Respiratory Rev. 18, 233\u2013243 (2009).","journal-title":"Eur. Respiratory Rev."},{"key":"523_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04786-0","volume":"22","author":"R Dong","year":"2024","unstructured":"Dong, R., Zhang, Q. & Peng, H. Gastroesophageal reflux disease and the risk of respiratory diseases: a mendelian randomization study. J. Transl. Med. 22, 60 (2024).","journal-title":"J. Transl. Med."},{"key":"523_CR25","doi-asserted-by":"publisher","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","volume":"10","author":"AA Lambert","year":"2015","unstructured":"Lambert, A. A. et al. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One 10, e0128004 (2015).","journal-title":"PLoS One"},{"key":"523_CR26","doi-asserted-by":"publisher","first-page":"i5813","DOI":"10.1136\/bmj.i5813","volume":"355","author":"F Othman","year":"2016","unstructured":"Othman, F., Crooks, C. J. & Card, T. R. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study. BMJ 355, i5813 (2016).","journal-title":"BMJ"},{"key":"523_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/14740338.2019.1577820","volume":"18","author":"CH Wang","year":"2019","unstructured":"Wang, C. H. et al. Proton pump inhibitors therapy and the risk of pneumonia: a systematic review and meta-analysis of randomized controlled trials and observational studies. Expert. Opin. Drug. Saf. 18, 163\u2013172 (2019).","journal-title":"Expert. Opin. Drug. Saf."},{"key":"523_CR28","first-page":"823","volume":"10","author":"H Kilic","year":"2015","unstructured":"Kilic, H., Kokturk, N., Sari, G. & Cak\u0131r, M. Do females behave differently in COPD exacerbation?. Int. J. Chron. Obstruct Pulmon Dis. 10, 823\u2013830 (2015).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"523_CR29","doi-asserted-by":"publisher","first-page":"1289259","DOI":"10.3389\/fmed.2024.1289259","volume":"11","author":"KM Milne","year":"2024","unstructured":"Milne, K. M., Mitchell, R. A., Ferguson, O. N., Hind, A. S. & Guenette, J. A. Sex-differences in COPD: from biological mechanisms to therapeutic considerations. Front. Med. 11, 1289259 (2024).","journal-title":"Front. Med."},{"key":"523_CR30","doi-asserted-by":"publisher","first-page":"2907","DOI":"10.2147\/COPD.S157761","volume":"13","author":"VYF Su","year":"2018","unstructured":"Su, V. Y. F. et al. Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD. Int. J. Chron. Obstruct Pulmon Dis. 13, 2907\u20132915 (2018).","journal-title":"Int. J. Chron. Obstruct Pulmon Dis."},{"key":"523_CR31","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1038\/ctg.2015.32","volume":"6","author":"ZH Hussain","year":"2015","unstructured":"Hussain, Z. H. et al. The proton pump inhibitor non-responder: a clinical conundrum. Clin. Transl. Gastroenterol. 6, e106 (2015).","journal-title":"Clin. Transl. Gastroenterol."}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00523-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00523-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T09:18:56Z","timestamp":1785748736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41533-026-00523-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["523"],"URL":"https:\/\/doi.org\/10.1038\/s41533-026-00523-4","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"53"}}